Coronary microvascular dysfunction (CMD) was an important independent component of ischemic heart disease, though it often ...

Michele Esposito, MD, an interventional-heart failure cardiologist and assistant professor of medicine at the Charleston-based Medical University of South Carolina, received a Mentored ...

Doctors may soon be able to diagnose an elusive form of heart disease within seconds by using an AI model developed at University of Michigan, according to a recent study. Researchers trained the ...

A new review highlights the potential role of single nucleotide polymorphisms (SNPs) in improving the early diagnosis and targeted intervention of coronary microvascular dysfunction (CMD)—a condition ...

A domestic collaborative research study has been published that prospectively analyzed the prevalence and prognosis of ...

Invasive coronary functional testing to identify the cause of angina in patients with nonobstructive coronary artery disease (ANOCA) can be performed safely at both experienced and less-experienced ...

ROCHESTER, Minn. — A study at Mayo Clinic suggests that an hourglass-shaped stent could improve blood flow and ease severe and reoccurring chest pain in people with microvascular disease. Of 30 ...

BAAR, Switzerland, July 07, 2025--(BUSINESS WIRE)--CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S.